Arkolith/Insider Trading/REPH/Form 4

Enloe J David JR

Chief Executive Officer, DirectorRecro Pharma, Inc. (REPH) · full profile →Form 4 · filed Nov 16, 2021
Net Buying
Open-Market Buys
$3K
Open-Market Sells
$0
Net Open-Market Flow
$3K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 12, 2021Buy(P)2K$1.68$3K154K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-21-044709) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML